Skip to main content
Erschienen in: World Journal of Urology 4/2011

01.08.2011 | Topic Paper

Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy

verfasst von: Thomas F. Chromecki, Behfar Ehdaie, Giacomo Novara, Karl Pummer, Richard Zigeuner, Christian Seitz, Armin Pycha, Richard K. Lee, Eugene K. Cha, Pierre I. Karakiewicz, Casey Ng, Jay D. Raman, Felix K. Chun, Hans-Martin Fritsche, Kazumasa Matsumoto, Wassim Kassouf, Thomas J. Walton, Patrick J. Bastian, Juan I. Martínez-Salamanca, Douglas S. Scherr, Shahrokh F. Shariat

Erschienen in: World Journal of Urology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Higher chronological age has been suggested to confer worse prognosis in patients with upper tract urothelial carcinoma (UTUC). The aim of the current study was to test this hypothesis in a large multicenter external validation cohort of patients treated with radical nephroureterectomy (RNU) while controlling for patient performance status.

Materials and methods

We retrospectively reviewed the data from 1,169 patients treated with RNU for UTUC. Age at RNU was analyzed both as a continuous and categorical variable (<50 years, n = 66; 50–59.9 years, n = 185; 60–69.9 years, n = 367; 70–79.9 years, n = 419; ≥80 years, n = 132). Median follow-up was 37 months.

Results

Actuarial recurrence-free, cancer-specific, and all-cause survival estimates at 5 years after RNU were 69, 73, and 61%, respectively. Advanced age was associated with female gender, higher ECOG status, higher ASA score, and a lower probability of receiving adjuvant chemotherapy (all P values ≤ 0.02). In multivariable analyses, advanced age was associated with decreased recurrence-free (P = 0.021), cancer-specific (P = 0.002), and all-cause survival (P < 0.001) after controlling for the effects of gender, tumor location, number of lymph nodes removed, tumor grade, stage, architecture, necrosis, and lymphovascular invasion. After addition of ECOG status, age remained an independent predictor of only all-cause mortality (P > 0.001).

Conclusions

We confirmed that advanced patient age at the time of RNU is associated with worse clinical outcomes after surgery. However, ECOG performance status abrogated the association. Furthermore, a large proportion of elderly patients were cured with RNU. This suggests that chronological age alone is an inadequate indicator criterion to predict response of older UTUC patients to RNU.
Literatur
1.
Zurück zum Zitat Scher H et al. (1998) NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park) 12(7A):225–271 Scher H et al. (1998) NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park) 12(7A):225–271
2.
Zurück zum Zitat Sun M et al (2010) Management of upper urinary tract urothelial carcinoma. Expert Rev Anticancer Ther 10(12):1955–1965PubMedCrossRef Sun M et al (2010) Management of upper urinary tract urothelial carcinoma. Expert Rev Anticancer Ther 10(12):1955–1965PubMedCrossRef
3.
Zurück zum Zitat Shariat S et al (2010) Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 105(12):1672–1677PubMedCrossRef Shariat S et al (2010) Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 105(12):1672–1677PubMedCrossRef
4.
Zurück zum Zitat Shariat SF, Milowsky M, Droller MJ (2009) Bladder cancer in the elderly. Urol Oncol 27(6):653–667PubMedCrossRef Shariat SF, Milowsky M, Droller MJ (2009) Bladder cancer in the elderly. Urol Oncol 27(6):653–667PubMedCrossRef
5.
Zurück zum Zitat Nielsen M et al. (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51(3):699–706 (discussion 706–708) Nielsen M et al. (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51(3):699–706 (discussion 706–708)
6.
Zurück zum Zitat Oken MM et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655PubMedCrossRef Oken MM et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655PubMedCrossRef
7.
Zurück zum Zitat Epstein JI (1998) The World Health Organization/International society of urological pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder consensus conference committee. Am J Surg Pathol 22(12):1435–1448PubMedCrossRef Epstein JI (1998) The World Health Organization/International society of urological pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder consensus conference committee. Am J Surg Pathol 22(12):1435–1448PubMedCrossRef
8.
Zurück zum Zitat Shariat SF et al (2010) International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105(10):1402–1412PubMedCrossRef Shariat SF et al (2010) International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105(10):1402–1412PubMedCrossRef
9.
Zurück zum Zitat Nielsen ME et al. (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51(3):699–706(discussion 706–708) Nielsen ME et al. (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51(3):699–706(discussion 706–708)
10.
Zurück zum Zitat EM M (2008) Urothelial tumors of the bladder. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh urology. Saunders-Elsevier, Philadeiphia, Amsterdam, pp 2407–2446 EM M (2008) Urothelial tumors of the bladder. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh urology. Saunders-Elsevier, Philadeiphia, Amsterdam, pp 2407–2446
11.
Zurück zum Zitat Benson RJ, Tomera K, Kelalis P (1983) Transitional cell carcinoma of the bladder in children and adolescents. J Urol 130(1):54–55PubMed Benson RJ, Tomera K, Kelalis P (1983) Transitional cell carcinoma of the bladder in children and adolescents. J Urol 130(1):54–55PubMed
12.
Zurück zum Zitat Fitzpatrick J, Reda M (1986) Bladder carcinoma in patients 40 years old or less. J Urol 135(1):53–54PubMed Fitzpatrick J, Reda M (1986) Bladder carcinoma in patients 40 years old or less. J Urol 135(1):53–54PubMed
13.
Zurück zum Zitat Linn J et al (1998) The molecular characteristics of bladder cancer in young patients. J Urol 159(5):1493–1496PubMedCrossRef Linn J et al (1998) The molecular characteristics of bladder cancer in young patients. J Urol 159(5):1493–1496PubMedCrossRef
14.
Zurück zum Zitat Madgar I et al (1988) Long-term followup of patients less than 30 years old with transitional cell carcinoma of bladder. J Urol 139(5):933–934PubMed Madgar I et al (1988) Long-term followup of patients less than 30 years old with transitional cell carcinoma of bladder. J Urol 139(5):933–934PubMed
15.
Zurück zum Zitat Witjes J, Debruyne F (1989) Bladder carcinoma in patients less than 40 years of age. Urol Int 44(2):81–83PubMedCrossRef Witjes J, Debruyne F (1989) Bladder carcinoma in patients less than 40 years of age. Urol Int 44(2):81–83PubMedCrossRef
16.
Zurück zum Zitat Resorlu B et al (2009) The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy. BJU Int 103(4):480–483PubMedCrossRef Resorlu B et al (2009) The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy. BJU Int 103(4):480–483PubMedCrossRef
17.
Zurück zum Zitat Shi B et al (2008) Relationship between patient age and superficial transitional cell carcinoma characteristics. Urology 71(6):1186–1190PubMedCrossRef Shi B et al (2008) Relationship between patient age and superficial transitional cell carcinoma characteristics. Urology 71(6):1186–1190PubMedCrossRef
18.
Zurück zum Zitat Johnson D, Hillis S (1978) Carcinoma of the bladder in patients less than 40 years old. J Urol 120(2):172–173PubMed Johnson D, Hillis S (1978) Carcinoma of the bladder in patients less than 40 years old. J Urol 120(2):172–173PubMed
19.
Zurück zum Zitat Kurz K, Pitts W, Vaughan EJ (1987) The natural history of patients less than 40 years old with bladder tumors. J Urol 137(3):395–397PubMed Kurz K, Pitts W, Vaughan EJ (1987) The natural history of patients less than 40 years old with bladder tumors. J Urol 137(3):395–397PubMed
20.
Zurück zum Zitat Kutarski P, Padwell A (1993) Transitional cell carcinoma of the bladder in young adults. Br J Urol 72(5 Pt 2):749–755 Kutarski P, Padwell A (1993) Transitional cell carcinoma of the bladder in young adults. Br J Urol 72(5 Pt 2):749–755
21.
Zurück zum Zitat Wan J, Grossman H (1989) Bladder carcinoma in patients age 40 years or younger. Cancer 64(1):178–181PubMedCrossRef Wan J, Grossman H (1989) Bladder carcinoma in patients age 40 years or younger. Cancer 64(1):178–181PubMedCrossRef
22.
Zurück zum Zitat Yossepowitch O, Dalbagni G (2002) Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. J Urol 168(1):61–66PubMedCrossRef Yossepowitch O, Dalbagni G (2002) Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. J Urol 168(1):61–66PubMedCrossRef
23.
Zurück zum Zitat Roscigno M et al (2009) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181(6):2482–2489PubMedCrossRef Roscigno M et al (2009) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181(6):2482–2489PubMedCrossRef
24.
Zurück zum Zitat Prout GR Jr (2005) Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 104(8):1638–1647PubMedCrossRef Prout GR Jr (2005) Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 104(8):1638–1647PubMedCrossRef
25.
Zurück zum Zitat Nielsen M et al (2007) A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int 100(5):1015–1020PubMed Nielsen M et al (2007) A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int 100(5):1015–1020PubMed
26.
Zurück zum Zitat Gore J et al (2009) Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a surveillance, epidemiology, and end results-medicare analysis. Cancer 115(5):988–996PubMedCrossRef Gore J et al (2009) Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a surveillance, epidemiology, and end results-medicare analysis. Cancer 115(5):988–996PubMedCrossRef
27.
Zurück zum Zitat Waldert M et al (2010) A delay in radical nephroureterectomy can lead to upstaging. BJU Int 105(6):812–817PubMedCrossRef Waldert M et al (2010) A delay in radical nephroureterectomy can lead to upstaging. BJU Int 105(6):812–817PubMedCrossRef
28.
Zurück zum Zitat Sesterhenn IA et al (1992) Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin Oncol 10(1):69–78PubMed Sesterhenn IA et al (1992) Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin Oncol 10(1):69–78PubMed
29.
Zurück zum Zitat Cheng L et al (2005) Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol 174(6):2181–2185PubMedCrossRef Cheng L et al (2005) Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol 174(6):2181–2185PubMedCrossRef
30.
Zurück zum Zitat Lapham RL, Grignon D, Ro JY (1997) Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens. Semin Diagn Pathol 14(2):109–122PubMed Lapham RL, Grignon D, Ro JY (1997) Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens. Semin Diagn Pathol 14(2):109–122PubMed
31.
Zurück zum Zitat Larsen MP et al (1990) Use of Ulex europaeus agglutinin I (UEAI) to distinguish vascular and “pseudovascular” invasion in transitional cell carcinoma of bladder with lamina propria invasion. Mod Pathol 3(1):83–88PubMed Larsen MP et al (1990) Use of Ulex europaeus agglutinin I (UEAI) to distinguish vascular and “pseudovascular” invasion in transitional cell carcinoma of bladder with lamina propria invasion. Mod Pathol 3(1):83–88PubMed
32.
Zurück zum Zitat Miyata Y et al (2006) Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. J Urol 176(1):348–353PubMedCrossRef Miyata Y et al (2006) Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. J Urol 176(1):348–353PubMedCrossRef
33.
Zurück zum Zitat Straume O, Jackson DG, Akslen LA (2003) Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 9(1):250–256PubMed Straume O, Jackson DG, Akslen LA (2003) Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 9(1):250–256PubMed
Metadaten
Titel
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy
verfasst von
Thomas F. Chromecki
Behfar Ehdaie
Giacomo Novara
Karl Pummer
Richard Zigeuner
Christian Seitz
Armin Pycha
Richard K. Lee
Eugene K. Cha
Pierre I. Karakiewicz
Casey Ng
Jay D. Raman
Felix K. Chun
Hans-Martin Fritsche
Kazumasa Matsumoto
Wassim Kassouf
Thomas J. Walton
Patrick J. Bastian
Juan I. Martínez-Salamanca
Douglas S. Scherr
Shahrokh F. Shariat
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 4/2011
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-011-0677-0

Weitere Artikel der Ausgabe 4/2011

World Journal of Urology 4/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.